Structure–Activity Relationship for the First??in??Class Clinical Steroid Sulfatase Inhibitor Irosustat (STX64, BN83495)
LW Woo, D Ganeshapillai, MP Thomas…
Index: Woo, L.W. Lawrence; Ganeshapillai, Dharshini; Thomas, Mark P.; Sutcliffe, Oliver B.; Malini, Bindu; Mahon, Mary F.; Purohit, Atul; Potter, Barry V.L. ChemMedChem, 2011 , vol. 6, # 11 p. 2019 - 2034
Full Text: HTML
Citation Number: 26
Abstract
Abstract Structure–activity relationship studies were conducted on Irosustat (STX64, BN83495), the first steroid sulfatase (STS) inhibitor to enter diverse clinical trials for patients with advanced hormone-dependent cancer. The size of its aliphatic ring was expanded; its sulfamate group was N, N-dimethylated, relocated to another position and flanked by an adjacent methoxy group; and series of quinolin-2 (1H)-one and quinoline derivatives of ...
Related Articles:
[Gribble, Gordon W.; Silva, Richard A. Tetrahedron Letters, 1996 , vol. 37, # 13 p. 2145 - 2148]
Design and synthesis of an orally active macrocyclic neutral endopeptidase 24.11 inhibitor
[MacPherson; Bayburt; Capparelli; Bohacek; Clarke; Ghai; Sakane; Berry; Peppard; Trapani Journal of Medicinal Chemistry, 1993 , vol. 36, # 24 p. 3821 - 3828]